1. Home
  2. XPON vs KPRX Comparison

XPON vs KPRX Comparison

Compare XPON & KPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expion360 Inc.

XPON

Expion360 Inc.

HOLD

Current Price

$0.68

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

Logo Kiora Pharmaceuticals Inc.

KPRX

Kiora Pharmaceuticals Inc.

N/A

Current Price

$2.35

Market Cap

8.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XPON
KPRX
Founded
2016
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
8.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
XPON
KPRX
Price
$0.68
$2.35
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
168.4K
619.1K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
94.63
N/A
EPS
N/A
N/A
Revenue
$9,651,870.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
71.59
N/A
52 Week Low
$0.49
$1.76
52 Week High
$5.50
$4.18

Technical Indicators

Market Signals
Indicator
XPON
KPRX
Relative Strength Index (RSI) 46.61 52.31
Support Level $0.65 $2.23
Resistance Level $0.84 $2.45
Average True Range (ATR) 0.06 0.11
MACD -0.01 -0.02
Stochastic Oscillator 15.34 22.03

Price Performance

Historical Comparison
XPON
KPRX

About XPON Expion360 Inc.

Expion360 Inc focuses on the design, assembly, manufacturing, and sale of lithium iron phosphate (LiFePO4) batteries and related accessories for RV, marine, and industrial applications. Its high-performance battery solutions are designed for high energy density and a compact footprint, supported by engineering and intellectual property to enhance safety, quality, and performance. The company also engages in product design, development, and collaboration to strengthen customer relationships. It serves dealers, wholesalers, private-label customers, and OEMs, who distribute its products to end consumers. Its segment is Energy Storage (ES), providing lithium-based energy solutions backed by durable materials, optimized internal structures, and responsive customer service.

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Share on Social Networks: